Patients in T3 group are more likely to have dyslipidemia, higher BMI, LDL-C, TG, TC, TG/HDL-C, Glu, UA, CRP, and lower HDL-C compared to the low TG/HDL-C group (P < 0.05). This evidence concerns the gene CRP and metabolic syndrome.